Challenges and dilemmas on universal coverage for non-communicable diseases in middle-income countries: evidence and lessons from Mexico
Tóm tắt
Despite more than 20 years of reform projects in health systems, the universal coverage strategy has not reached the expected results in most middle-income countries (MICs). Using evidence from the Mexican case on diabetes and hypertension as tracers of non-communicable diseases, the effective coverage rate barely surpasses half of the expected goals necessary to meet the challenges that these two diseases represent at the population level. Prevalence and incidence rates do not diminish either; they even grow. In terms of the economic burden, this means that lack of financial protection and catastrophic expense rates have increased, contrary to what could have been expected. As any complex system, health systems present challenges and dilemmas that are difficult to solve. In terms of universal coverage, when contrasting normative coverage versus effective coverage, the epidemiological, cultural, organizational and economic challenges and barriers become evident. Such challenges have not allowed a greater effectiveness of the contributions of state of the art medicine in the resolution of health problems, particularly in relation to diabetes and hypertension. Despite of the existence of many universal coverage projects, strategies and programs implemented in MICs, challenges remain and, far from disappearing, unresolved problems are still present, even with increasing trends. The model of care based on a curative biomedical approach was enough to respond to the health needs of the last century, but is no longer adapted to the needs of the present century. The dilemmas of continuity vs. rupture require to review and discuss the background and structure of health systems and their underlying models of care. These two elements have not allowed the different coverage schemes to guarantee greater effectiveness in the application of state of the art medicine, nor a greater health care financial protection for patients and their families. We thus can either accept the fragmented health systems and bio-medical-curative models of care approach or, instead, we can move towards integrated health systems that would be based on a socio-medical-preventive approach to health care.
Tài liệu tham khảo
Sojo A. Condiciones para el acceso universal a la salud en América Latina: derechos sociales, protección social y restricciones financieras y políticas Ciência & Saúde Coletiva. Cien Saude Colet. 2011;16(6):2673–85.
WHO. Universal eye health: a global action plan 2014–2019. Geneva: World Health Organization. http://www.who.int/blindness/AP2014_19_English.pdf?ua=1. Accessed 5 Jan 2018.
Tamez González S, Eibenschutz C. Popular Health Insurance: key piece of inequity in health in Mexico Silvia. Rev. salud pública. 2008, Vol 10 sup (1): 133–145.
WHO. World Health Report. Health systems financing. Path to universal coverage. Geneva: World Health Organization. 2010;2010:12–24.
Comisión Nacional de Protección Social en Salud. Enrolled population up to June 2015.17 [accesed november 2017]. Disponible en: https://www.gob.mx/salud%7Cseguropopular/que-hacemos.
Estevez R. The quest for equity in Latin America: a comparative analysis of the health care reforms in Brazil and Colombia. International J Equity and Health. 2012;11:6.
Benedict R, et al. Universal coverage, priority setting, and the human right to health. Lancet. 2017;390(10095):712–4.
Bennett S, Ozawa S, Rao KD. Which path to universal health coverage? Perspectives on the world health report 2010. PLoS Med. 2010;7:e1001001.
SSA informes Salud 2000–2010. Mexico. Secretaría de Salud de México: información para la rendición de cuentas, Secretaría de Salud, México, DF, 2010: 32–52.
SSA-Secretaría de Salud. Programa Nacional de Salud 2001-2006. La democratización de la salud en México: Hacia un sistema universal de salud. México: Secretaría de Salud. p. 2007.
The world health report. Research for universal health coverage. Geneva: World Health Organization; 2013.
Lozano R, Soliz P, Gakidou E, Abbott-Klafter J, Feehan DM, et al. Benchmarking of performance of Mexican states with effective coverage. Lancet. 2006;368:1729–41. https://doi.org/10.1016/S0140-6736(06)69566-4.
World Bank. Universal healthcare on the rise in Latin America. Washington D.C: Working Paper; 2013.
Universal eye health: a global action plan 2014–2019. Geneva: World Health Organization;2013 (http://www.who.int/blindness/AP2014_19_English.pdf?ua=1. Accessed 15 Apr 2015).
Suarez J. Desafíos para alcanzar universalidad con equidad en salud en América Latina en el siglo XXI. Revista Cubana de Salud Pública. 2010;36(3):248–54.
NIPH. National Institute of public health. Project: costs and financing consequences from changes in epidemiological profile on chronic diseases. Final Technical Report. 1995-2016;2017:18–22.
Arredondo A, Avilés R. Costs and Epidemiological Changes of Chronic Diseases: Implications and Challenges for Health Systems. Rev. Plos One. 2016;10(3):e0118611.
American Diabetes Association. Metabolic Contrasts between Youth and Adults with Impaired Glucose Tolerance or Recently Diagnosed Type 2 Diabetes: I. Observations Using the Hyperglycemic Clamp. Diabetes Care. 2018:1–10. https://doi.org/10.2337/dc18-0244
Carey R, Whelton P. The 2017 American College of Cardiology/American Heart Association hypertension guideline: a resource for practicing clinicians. Ann Intern Med. 2018;168(5):359–60.
Arredondo A. Diabetes duration, HbA1c, and cause-specific mortality in Mexico. Lancet Diabetes & Endocrinology. 2018;6(6):429–31.
Secretaría de Salud. Recursos financieros. Boletín de Información Estadística 2005-2015; México: Dirección General de Información en Salud, Secretaría de Salud. [Consultado marzo 22, 2017]. Disponible en: http://www.dgis.salud.gob.mx/contenidos/sinais/indica_gral.html.
Atun R, Monteiro de Andrade, Braga J, Health-system reform and universal health coverage in Latin America. Lancet 2014; publicado en línea 16 de octubre 2014. Disponible en: https://doi.org/10.1016/S0140-6736(14)61646-9.
de Salud S. In: de Salud S, editor. Programa de Reforma del Sector Salud, 2007-2012, vol. 2016. México: Poder Ejecutivo Federal; 2013-2018. p. 1–56.
National Institute of Public Health. Métodos de estimación de cambios epidemiológicos y demanda esperada de enfermedades crónico-degenerativas. México: Informe Técnico de Memoria Metodológica. Cuernavaca; 2015. p. 12–23.
Zhang P, Zhang X, Brown J, Vistisen D, Sicree R. Global healthcare expenditure on diabetes for 2010 and 2030. Diabetes Research. 2010;87:293–301.
Barcelo A, Arredondo A, Escobar A, Quiang A. The cost of diabetes in Latin America and the Caribbean in 2015: evidence for decision and policy makers. Jou of Global Health. 2017;7(2):1–15.
Arredondo A, Aviles R, Costs and Epidemiological Changes of Chronic Diseases: Implications and Challenges for Health Systems. Plos One, 2015 (10), Num 3 e0118611.
Gutiérrez JP, Hernández-Ávila M. Cobertura de protección en salud en México, 2000–2012. Salud Publica Mex 2013;55(supl 2):S83-S90.
WHO Global Health Expenditure database 2016. Accessed online October 2017. http://www.who.int/gho/health_financing/en/.
Fajardo-Dolci G, Gutiérrez JP, García-Saisó S. Effective access to health services: operationalizing universal health coverage. Salud Publica Mex. 2015;57:180–6.
National Academy of Medicine. Acciones para enfrentar la diabetes. Impacto Economico de la diabetes, retos y soluciones. Mexico: NAM Ed; 2014. p. 269–86.
National Institute of Public Health. Métodos de estimación de cambios epidemiológicos y demanda esperada de enfermedades crónico-degenerativas. México: Informe Técnico de Memoria Metodológica. Cuernavaca; 2015. p. 30–7.
OECD. Indicators of public spending and out-of-pocket spending on health in different countries. Health at a Glance 2017: OECD Indicators - OECD.org: 2017: 3–4. (accessed online June-20018) https://www.oecd.org/mexico/Health-at-a-Glance-2017-Key-Findings-MEXICO-in-English.pdf.
WHO. Data Tracking Universal Health Coverage: first global monitoring report. Library Cataloguing-in-Publication. Coverage health interventions: Hypertension and Diabetes. 2017:26–28. (accessed on line June 2018). www.who.int/about/licensing/copyright_form/en/index.html.
Bleich SN, Cutler DM, Adams AS, Lozano R, Murray CJL. Impact of insurance and supply of health professionals on coverage of treatment for hypertension in Mexico: population based study. Br Med J. 2007;335:875.
Reddy KS, Patel V, Jha P, Paul VK, Shiva Kumar AK, Dandona L. Towards achievement of universal health care in India by 2020: a call toaction. Lancet. 2012;377:760–8.
Boerma T, AbouZahr C, Evans D, Evans T. Monitoring intervention coverage in the context of universal health coverage. PLoS Med. 2014;11:e1001728.
SSA. Informe sobre la salud de los mexicanos 2016 Diagnóstico General del Sistema Nacional de Salud Primera edición, 2016 Mexico. Available at: (accessed online Hune 2018). http://www.gob.mx/salud/acciones-y-programas/direccion-general-de-evaluacion-del-desempeno?idiom=es-MX.
INSP. National Health and Nutrition Survey 2016 (ENSANUT). Historical trends in chronic diseases. Final Report. Mexico. SSA-INSP, 2016: 46–49. (Accessed on line, January, 2018). https://www.insp.mx/avisos/4576-resultados-ensanut-mc-2016.html.
Omran AR. The epidemiologic transition: a theory of the epidemiology of population change. Milbank Memorial Fund Quaterly. 1971;49:509–38.
Frenk J, Bobadilla JL, Stern C, Lozano R. The epidemiological transition in Latin America. Bol Oficina Sanit Panam. 1991;111:485–96.
Olshansky SJ, Ault AB. The fourth stage of the epidemiologic transition: the age of delayed degenerative diseases. Milbank Q. 1986;64:355–91.
Porter M. A strategy for health care reform. Toward a value-based system. N Engl J Med. 2009;361:109–12.
Cortez R, Romero D. Increasing utilization of health care services among the uninsured population: the plan Nacer program. Working paper no. 74956. World Bank Series: Buenos Aires; 2013.
Arredondo A. Changing paradigms and challenges: evidence on the epidemiological and economic burden of diabetes in Latin America. Diabet Med. 2017;34(7):1009–10.
Giedion U. Designing and implementing explicit health benefits packages in Latin America. In: In Report of the Roundtable Discussion on Universal Health Coverage. Washington D.C: Policy Wisdom; 2013. p. 6–7.
Barzansky B.Abraham Flexner and the era of medical education reform. Acad Med 2010 Sep;85(9Suppl):S19–S25.
Monteiro de Andrade LO, Pellegrini Filho A, Solar O, Rígoli F, Malagón de Salazar L, Pastor Castell-Florit, et al. Determinantes sociales de salud, cobertura universal de salud, y desarrollo sostenible: estudios de casos en países latinoamericanos. MEDICC Rev. 2015;17 Suppl:S53–S61.
WHO. Closing the gap: Policy into practice on social determinants of health. In: de Janeiro R, editor. World conference on social Determinants of Health. Rio de Janeiro: WHO; 2011. p. 47.
Salomon JA, Carvalho N, Gutiérrez-Delgado C. Intervention strategies to reduce the burden of non-communicable diseases in Mexico: cost effectiveness analysis. BMJ. 2012;344:e355. https://doi.org/10.1136/bmj.e355.
WHO-World Bank. Tracking universal health coverage: first global monitoring report. In: Universal Coverage and Healthcare Financing. Health Services Accessibility, Monitoring Financial Protection. Geneve: WHO; 2015. p. 18–56.
Rodin J, de Ferranti D. Universal health coverage: the third global health transition? Lancet. 2012;380:861–2.
Lai T, Habicht T, Jesse M. Monitoring and evaluating progress towards universal health coverage in Estonia. PLoS Med. 2014;11(9):e1001677.
Arredondo A, Orozco E, Alcalde J, Navarro J. Carga económica y epidemiológica de Diabetes e Hipertension en México. Saud Pub de Brasil. 2018;52:1–23.
Arredondo A. Type 2 diabetes and health care costs in Latin America: exploring the need for greater preventive medicine. BMC Med. 2014;12(136):11–9.